Asterias Biotherapeutics, Inc. Research and Development in Process
Asterias Biotherapeutics, Inc. reported Research and Development in Process of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2016-03-29
- Asterias Biotherapeutics, Inc. research and development in process for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- Asterias Biotherapeutics, Inc. research and development in process for the quarter ending 2014-09-30 was $0.00.
- Asterias Biotherapeutics, Inc. research and development in process for the quarter ending 2014-06-30 was $0.00.
- Asterias Biotherapeutics, Inc. research and development in process for the quarter ending 2014-03-31 was $0.00.
- Asterias Biotherapeutics, Inc. research and development in process for fiscal 2015 was $0.00.
- Asterias Biotherapeutics, Inc. research and development in process for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- Asterias Biotherapeutics, Inc. research and development in process for fiscal 2013 was $17.46M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 6 month | Research and Development in Process 9 month | Research and Development in Process 12 month | Research and Development in Process 12 month as first filed | Research and Development in Process 18 month | Research and Development in Process 21 month | Research and Development in Process 24 month | Research and Development in Process 27 month |
|---|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-29 | ||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $0.00 derived: sum of 2 quarters · filed 2016-03-29 | $0.00 derived: sum of 3 quarters · filed 2016-03-29 | $0.00 10-K · filed 2016-03-29 | $17.46M 10-K · filed 2015-03-11 | ||||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | $17.46M derived: sum of 4 quarters · filed 2016-03-29 | $17.46M 10-Q · filed 2014-11-10 | ||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $17.46M derived: sum of 3 quarters · filed 2016-03-29 | $17.46M derived: sum of 4 quarters · filed 2016-03-29 | $17.46M 10-Q · filed 2014-08-11 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | $17.46M derived: sum of 2 quarters · filed 2016-03-29 | $17.46M derived: sum of 3 quarters · filed 2016-03-29 | $17.46M derived: sum of 4 quarters · filed 2016-03-29 | $17.46M 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | $17.46M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $17.46M derived: sum of 2 quarters · filed 2016-03-29 | $17.46M derived: sum of 3 quarters · filed 2016-03-29 | $17.46M 10-K · filed 2016-03-29 | $17.46M 10-K · filed 2015-03-11 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 4 quarters · filed 2015-03-11 | |||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-11 | $0.00 10-Q · filed 2014-08-11 | $0.00 derived: sum of 3 quarters · filed 2015-03-11 | ||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2015-03-11 | |||||||
| 2012-12-31 | $0.00 10-K · filed 2015-03-11 |